Biogen corporate headquaters on Binney Street in Cambridge, MA.
W. Marc Bernsau | Boston Business Journal
Spring is the time of the birds and the bees, but they aren't the only ones keeping busy. Boston's biotech and life sciences were also busy in May. Check out last month's mergers and acquisitions, courtesy of reporting by BostInno and the Boston Business Journal in May.
And don't forget to sign up for The Beat, BostInno's free daily innovation newsletter, so you never miss an M&A deal.
- Meat delivery startup ButcherBox made its first acquisition since its launch after purchasing Truffle Shuffle.
- Novartis acquired Mariana Oncology, a Watertown cancer treatment startup for $1 billion upfront. Mariana is eligible for up to $750 million in potential milestone payments.
- Cambridge-based Akamai Technologies signed a $450 million deal to buy Noname Security, a San Jose-based firm with a valuation of over $1 billion in 2021.
- Arbor Biotechnologies in Cambridge acquired gene-editing firm Serendipity Biosciences.
- Avangrid Inc., the co-owner of Vineyard Wind, agreed to be acquired by its majority shareholder, Iberdrola S/A.
- Biogen acquired the San Francisco startup Human Immunology Biosciences for $1.15B upfront. The acquisition could involve up to $650M in milestone payments.
- Watertown's Orna Therapeutics, a circular RNA startup, acquired Cambridge-based ReNAgade Therapeutics.
- DraftKings acquired Jackpocket, the largest lottery app in the U.S, for $750 million.
- Akili Inc., a Boston-based therapeutic video game maker, merged with Virtual Therapeutics.
